Evidence for lymphatic Aβ clearance in Alzheimer's transgenic mice

Miguel Pappolla, Kumar Sambamurti, Ruben Vidal, Javier Pacheco-Quinto, Burkhard Poeggeler, Etsuro Matsubara

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Evidence has shown that lymphatic drainage contributes to removal of debris from the brain but its role in the accumulation of amyloid β peptides (Aβ) has not been demonstrated. We examined the levels of various forms of Aβ in the brain, plasma and lymph nodes in a transgenic model of Alzheimer's disease (AD) at different ages. Herein, we report on the novel finding that Aβ is present in the cervical and axillary lymph nodes of AD transgenic mice and that Aβ levels in lymph nodes increase over time, mirroring the increase of Aβ levels observed in the brain. Aβ levels in lymph nodes were significantly higher than in plasma. At age 15.5. months, there was a significant increase of monomeric soluble Aβ40 (p= 0.003) and Aβ42 (p= 0.05) in the lymph nodes over the baseline values measured at 6. months of age. In contrast, plasma levels of Aβ40 showed no significant changes (p= 0.68) and plasma levels Aβ42 significantly dropped (p= 0.02) at the same age. Aβ concentration was low to undetectable in splenic lymphoid tissue and several other control tissues including heart, lung, liver, kidneys and intestine of the same animals, strongly suggesting that Aβ peptides in lymph nodes are derived from the brain.

Original languageEnglish (US)
Pages (from-to)215-219
Number of pages5
JournalNeurobiology of Disease
Volume71
DOIs
StatePublished - 2014

Fingerprint

Transgenic Mice
Lymph Nodes
Brain
Alzheimer Disease
Lymphoid Tissue
Amyloid
Intestines
Drainage
Kidney
Lung
Peptides
Liver

Keywords

  • Alzheimer's disease
  • Amyloid beta protein
  • Lymph node
  • Protein clearance

ASJC Scopus subject areas

  • Neurology

Cite this

Pappolla, M., Sambamurti, K., Vidal, R., Pacheco-Quinto, J., Poeggeler, B., & Matsubara, E. (2014). Evidence for lymphatic Aβ clearance in Alzheimer's transgenic mice. Neurobiology of Disease, 71, 215-219. https://doi.org/10.1016/j.nbd.2014.07.012

Evidence for lymphatic Aβ clearance in Alzheimer's transgenic mice. / Pappolla, Miguel; Sambamurti, Kumar; Vidal, Ruben; Pacheco-Quinto, Javier; Poeggeler, Burkhard; Matsubara, Etsuro.

In: Neurobiology of Disease, Vol. 71, 2014, p. 215-219.

Research output: Contribution to journalArticle

Pappolla, M, Sambamurti, K, Vidal, R, Pacheco-Quinto, J, Poeggeler, B & Matsubara, E 2014, 'Evidence for lymphatic Aβ clearance in Alzheimer's transgenic mice', Neurobiology of Disease, vol. 71, pp. 215-219. https://doi.org/10.1016/j.nbd.2014.07.012
Pappolla, Miguel ; Sambamurti, Kumar ; Vidal, Ruben ; Pacheco-Quinto, Javier ; Poeggeler, Burkhard ; Matsubara, Etsuro. / Evidence for lymphatic Aβ clearance in Alzheimer's transgenic mice. In: Neurobiology of Disease. 2014 ; Vol. 71. pp. 215-219.
@article{9e539005912d4775a7c7be5fe0e02b63,
title = "Evidence for lymphatic Aβ clearance in Alzheimer's transgenic mice",
abstract = "Evidence has shown that lymphatic drainage contributes to removal of debris from the brain but its role in the accumulation of amyloid β peptides (Aβ) has not been demonstrated. We examined the levels of various forms of Aβ in the brain, plasma and lymph nodes in a transgenic model of Alzheimer's disease (AD) at different ages. Herein, we report on the novel finding that Aβ is present in the cervical and axillary lymph nodes of AD transgenic mice and that Aβ levels in lymph nodes increase over time, mirroring the increase of Aβ levels observed in the brain. Aβ levels in lymph nodes were significantly higher than in plasma. At age 15.5. months, there was a significant increase of monomeric soluble Aβ40 (p= 0.003) and Aβ42 (p= 0.05) in the lymph nodes over the baseline values measured at 6. months of age. In contrast, plasma levels of Aβ40 showed no significant changes (p= 0.68) and plasma levels Aβ42 significantly dropped (p= 0.02) at the same age. Aβ concentration was low to undetectable in splenic lymphoid tissue and several other control tissues including heart, lung, liver, kidneys and intestine of the same animals, strongly suggesting that Aβ peptides in lymph nodes are derived from the brain.",
keywords = "Alzheimer's disease, Amyloid beta protein, Lymph node, Protein clearance",
author = "Miguel Pappolla and Kumar Sambamurti and Ruben Vidal and Javier Pacheco-Quinto and Burkhard Poeggeler and Etsuro Matsubara",
year = "2014",
doi = "10.1016/j.nbd.2014.07.012",
language = "English (US)",
volume = "71",
pages = "215--219",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Evidence for lymphatic Aβ clearance in Alzheimer's transgenic mice

AU - Pappolla, Miguel

AU - Sambamurti, Kumar

AU - Vidal, Ruben

AU - Pacheco-Quinto, Javier

AU - Poeggeler, Burkhard

AU - Matsubara, Etsuro

PY - 2014

Y1 - 2014

N2 - Evidence has shown that lymphatic drainage contributes to removal of debris from the brain but its role in the accumulation of amyloid β peptides (Aβ) has not been demonstrated. We examined the levels of various forms of Aβ in the brain, plasma and lymph nodes in a transgenic model of Alzheimer's disease (AD) at different ages. Herein, we report on the novel finding that Aβ is present in the cervical and axillary lymph nodes of AD transgenic mice and that Aβ levels in lymph nodes increase over time, mirroring the increase of Aβ levels observed in the brain. Aβ levels in lymph nodes were significantly higher than in plasma. At age 15.5. months, there was a significant increase of monomeric soluble Aβ40 (p= 0.003) and Aβ42 (p= 0.05) in the lymph nodes over the baseline values measured at 6. months of age. In contrast, plasma levels of Aβ40 showed no significant changes (p= 0.68) and plasma levels Aβ42 significantly dropped (p= 0.02) at the same age. Aβ concentration was low to undetectable in splenic lymphoid tissue and several other control tissues including heart, lung, liver, kidneys and intestine of the same animals, strongly suggesting that Aβ peptides in lymph nodes are derived from the brain.

AB - Evidence has shown that lymphatic drainage contributes to removal of debris from the brain but its role in the accumulation of amyloid β peptides (Aβ) has not been demonstrated. We examined the levels of various forms of Aβ in the brain, plasma and lymph nodes in a transgenic model of Alzheimer's disease (AD) at different ages. Herein, we report on the novel finding that Aβ is present in the cervical and axillary lymph nodes of AD transgenic mice and that Aβ levels in lymph nodes increase over time, mirroring the increase of Aβ levels observed in the brain. Aβ levels in lymph nodes were significantly higher than in plasma. At age 15.5. months, there was a significant increase of monomeric soluble Aβ40 (p= 0.003) and Aβ42 (p= 0.05) in the lymph nodes over the baseline values measured at 6. months of age. In contrast, plasma levels of Aβ40 showed no significant changes (p= 0.68) and plasma levels Aβ42 significantly dropped (p= 0.02) at the same age. Aβ concentration was low to undetectable in splenic lymphoid tissue and several other control tissues including heart, lung, liver, kidneys and intestine of the same animals, strongly suggesting that Aβ peptides in lymph nodes are derived from the brain.

KW - Alzheimer's disease

KW - Amyloid beta protein

KW - Lymph node

KW - Protein clearance

UR - http://www.scopus.com/inward/record.url?scp=84906825339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906825339&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2014.07.012

DO - 10.1016/j.nbd.2014.07.012

M3 - Article

C2 - 25102344

AN - SCOPUS:84906825339

VL - 71

SP - 215

EP - 219

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

ER -